- Cullinan Therapeutics Chief Scientific Officer Jennifer Michaelson sold 8,000 common shares on Sept. 8 at **$21.57**. - She exercised stock options for 4,000 shares the same day at **$4.30**. - Directly held common shares fell to **158,844**.